AIP
SLS icon

Ameritas Investment Partners’s SELLAS Life Sciences SLS Stock Holding History

Ameritas Investment Partners’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Buy
17,129
+3,064
+22% +$21.2K 0.01% 1255
2026
Q1 		$59.5K Buy
14,065
+4,321
+44% +$19.3K ﹤0.01% 1995
2025
Q4 		$36.7K Hold
9,744
– – ﹤0.01% 2330
2025
Q3 		$15.7K Hold
9,744
– – ﹤0.01% 2782
2025
Q2 		$21.3K Buy
+9,744
New +$15K ﹤0.01% 2625

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Ameritas Investment Partners's SLS Position: Q2 2026 in Review

Ameritas Investment Partners increased its SELLAS Life Sciences (SLS) stake by 22% in Q2 2026, buying an estimated $21.2K and bringing the position to 17,129 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #1255.

Ameritas Investment Partners first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Ameritas Investment Partners held 17,129 shares of SELLAS Life Sciences worth $253K as of Q2 2026.
  • Ameritas Investment Partners bought 3,064 SELLAS Life Sciences shares in Q2 2026, an estimated $21.2K.
  • SELLAS Life Sciences made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1255 holding.
  • Ameritas Investment Partners first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.